Hallek Michael

Michael Hallek is a professor of medicine and director of the Department of Internal Medicine I at the University Hospital of Cologne, Germany. He is director of the Center for Integrated Oncology (CIO) in Cologne and has served as the center’s chair since 2007. He received his medical degree from the University of Munich, Germany, in 1985 and trained in pharmacology and internal medicine at the Technical University of Munich. Prof. Hallek spent 2 years as a research associate at the Dana-Farber Cancer Institute at Harvard Medical School, Boston, MA, USA. He then returned to Germany to complete his training in internal medicine, hematology, and oncology at the University of Munich, where he has since held a number of roles, including head of the gene therapy program, senior consultant, and professor. Since 2003, he has also held the positions of full professor of internal medicine and chair at the University of Cologne.

In 1996, Prof. Hallek became founder and chair of the German CLL Study Group. He is a member of the German National Academy of Sciences Leopoldina and has received numerous awards, including the Paul Martini Prize (2012), the Binet-Rai Medal (2013), the German Cancer Award (2017), and the European Hematology Association (EHA)’s José Carreras Award (2019). In 2018, he presented the Ham-Wasserman lecture for the American Society of Hematology (ASH). 

Prof. Hallek was president of the German Society of Internal Medicine (DGIM) from 2014 to 2015 and chair of the German Society of Hematology and Medical Oncology (DGHO) from 2016 to 2019. He is the current chair of the Scientific Committee of the European School of Haematology in Paris, France, and a member of the Strategy Advisory Board “National Decade Against Cancer” of the Federal Ministry of Education and Research (BMBF). Since 2020, he has been the associate editor for the journal Blood.